Motavizumab (MEDI-524) is a monoclonal antibody neutralizing respiratory syncytial virus (RSV), altering local and systemic cytokine responses in mouse models, used in the study of RSV infection.
Purity:
>95%
CAS Number:
[677010-34-3]
Target:
RSV
* VAT and and shipping costs not included. Errors and price changes excepted